pre-ipo
Stage
About
Olema Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted therapies for metastatic breast cancer and endocrine-driven cancers using novel treatments based on nuclear receptors and mechanisms of acquired resistance.
Explore Olema Pharmaceuticals, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.